Respirerx Pharmaceuticals Inc (RSPI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2018 | 06-2018 | 03-2018 | 12-2017 | 09-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 81 | 1 | 0 | 85 | 52 |
| Other current assets | 49 | 49 | 49 | 49 | 49 |
| TOTAL | $197 | $132 | $150 | $177 | $162 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 7 | 11 | 14 | 18 | 22 |
| TOTAL | $7 | $11 | $14 | $18 | $22 |
| Total Assets | $204 | $143 | $164 | $195 | $184 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,254 | 3,135 | 3,049 | 2,922 | 2,958 |
| Accrued Expenses | 1,116 | 837 | 758 | 479 | 2,757 |
| TOTAL | $5,563 | $5,212 | $5,141 | $4,550 | $6,950 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $5,563 | $5,212 | $5,141 | $4,550 | $6,950 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 359 | 359 | 312 | 312 | 263 |
| Common Shares | 4 | 3 | 3 | 3 | 3 |
| Retained earnings | -163,720 | -163,184 | -162,549 | -161,802 | -161,183 |
| Other shareholders' equity | 22 | 22 | 22 | 22 | 22 |
| TOTAL | $-5,359 | $-5,069 | $-4,977 | $-4,355 | $-6,766 |
| Total Liabilities And Equity | $204 | $143 | $164 | $195 | $184 |